Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
04/24/2014 | WO2014062703A1 Genetically engineered microorganisms for biological oxidation of hydrocarbons |
04/24/2014 | WO2014062686A1 Methods for modulating c9orf72 expression |
04/24/2014 | WO2014062580A1 Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens |
04/24/2014 | WO2014062544A2 Methods and compositions to enhance activity of cry endotoxins |
04/24/2014 | WO2014062535A1 Mammalian cell culture processes for protein production |
04/24/2014 | WO2014062442A1 Use of microrna for assessing fertility in a female patient |
04/24/2014 | WO2014062134A1 Compounds and methods for the production of suckerin and uses thereof |
04/24/2014 | WO2014062069A1 Shon as a prognostic biomarker for cancer and as a predictor of response to endocrine therapy |
04/24/2014 | WO2014062036A1 Gene delivery system for transformation of plant using plant virus and uses thereof |
04/24/2014 | WO2014061932A1 Production method for genetically modified plant having enhanced immune capacity with respect to pathogenic microorganisms using reca1 gene derived from arabidopsis thaliana, and plant therefrom |
04/24/2014 | WO2014061829A1 Method for evaluating both induction of drug-metabolizing enzyme and cytotoxicity, and vector and cell for use in said method |
04/24/2014 | WO2014061819A1 Method for synthesizing complementary dna |
04/24/2014 | WO2014061805A1 Method for manufacturing l-amino acid |
04/24/2014 | WO2014061804A1 Method for producing l-amino acid |
04/24/2014 | WO2014061783A1 Human antibody specific to toxin produced from clostridium difficile, or antigen-binding fragment thereof |
04/24/2014 | WO2014061763A1 Novel xylanase |
04/24/2014 | WO2014061735A1 NOVEL HIGH-FUNCTIONING ENZYME HAVING ALTERED HUMAN β-HEXOSAMINIDASE B SUBSTRATE SPECIFICITY, AND HAVING PROTEASE RESISTANCE APPLIED THERETO |
04/24/2014 | WO2014061459A1 Method for producing glycolipid |
04/24/2014 | WO2014061419A1 Novel cancer marker and utilization thereof |
04/24/2014 | WO2014061146A1 Gene analysis method, and device and kit for analysis of gene |
04/24/2014 | WO2014060998A1 Integrated microfluidic component for enriching and extracting biological cell components |
04/24/2014 | WO2014060905A1 Recombinant novirhabdovirus usable as an antigen vector |
04/24/2014 | WO2014060678A1 Yeast strains for the production of biomass on a substrate comprising a c5 sugar |
04/24/2014 | WO2014060594A1 Production of a hcmv based vaccine in human amniocyte cell lines |
04/24/2014 | WO2014060580A1 Lxvp-mediated calcineurin inhibition in macrophages |
04/24/2014 | WO2014060427A2 Electrocompetent cells and preparation thereof |
04/24/2014 | WO2014060397A1 Factor vii conjugates |
04/24/2014 | WO2014060392A1 Caspase-6 inhibitors for treating t cell activation and/or proliferation disorders |
04/24/2014 | WO2014059789A1 Asparaginic acid kinase iii mutant and host cells and use thereof |
04/24/2014 | WO2014059544A1 Transgenic cells for identifying gpcr signaling compound modulating gpcr signaling pathway and screening method thereof |
04/24/2014 | WO2014059541A1 Novel cell wall deconstruction enzymes of thermoascus aurantiacus, myceliophthora fergusii (corynascus thermophilus), and pseudocercosporella herpotrichoides, and uses thereof |
04/24/2014 | WO2014036524A3 Genetically modified msc and therapeutic methods |
04/24/2014 | WO2014036014A3 Dominant negative transcription factor for antagonizing oncogenic transcription factors via multimerization |
04/24/2014 | WO2014022739A9 Modified rnai agents |
04/24/2014 | WO2014004683A3 Methods and composition for enhanced forage quality |
04/24/2014 | WO2013185193A8 Method for producing and obtaining variable domains of anti-digoxin monoclonal antibody fab fragment using the molecular biology cloning technique |
04/24/2014 | WO2013184764A3 Construct and method for expressing transgenes using a brassica bidirectional constitutive promoter |
04/24/2014 | WO2013049307A3 Enhanced immune memory development by aptamer targeted mtor inhibition of t cells |
04/24/2014 | WO2012106465A3 Methods and compositions for increasing sialic acid production and treating sialic related disease conditions |
04/24/2014 | WO2010099500A8 Beta-glucosidase variant enzymes and related polynucleotides |
04/24/2014 | US20140115738 Yield enhancement in plants by modulation of a maize wspl1 protein |
04/24/2014 | US20140115737 Transgenic plants with enhanced agronomic traits |
04/24/2014 | US20140115736 Hybrid seed potato breeding |
04/24/2014 | US20140115735 Cucurbita plant resistant to potyvirus |
04/24/2014 | US20140115734 Rice cultivar calhikari-202 |
04/24/2014 | US20140115733 Lettuce cultivar fusion |
04/24/2014 | US20140115731 Screening methods |
04/24/2014 | US20140115728 Double knockout (gt/cmah-ko) pigs, organs and tissues |
04/24/2014 | US20140114057 Antisense compounds targeting genes associated with usher syndrome |
04/24/2014 | US20140113966 Perhydrolase variant providing improved specific activity |
04/24/2014 | US20140113958 HCV Combination Therapy |
04/24/2014 | US20140113957 Compositions and Methods for Inhibition of Expression of Apolipoprotein C-III (APOC3) Genes |
04/24/2014 | US20140113955 METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA |
04/24/2014 | US20140113954 The Micrornaome |
04/24/2014 | US20140113953 Targeting MicroRNAs for Metabolic Disorders |
04/24/2014 | US20140113952 Transposable elements, tdp-43, and neurodegenerative disorders |
04/24/2014 | US20140113951 Method of Treating Cancer by Inhibition of DNA Repair Proteins |
04/24/2014 | US20140113950 Interference in dermal and fibrotic indications |
04/24/2014 | US20140113377 Genetic manipulation and expression systems for pucciniomycotina and ustilaginomycotina subphyla |
04/24/2014 | US20140113375 Transient Expression And Reverse Transcription Aided Genome Alteration System |
04/24/2014 | US20140113368 Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements |
04/24/2014 | US20140113304 Bi-Directional Cytosine Deaminase-Encoding Selection Marker |
04/24/2014 | US20140113285 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection |
04/24/2014 | US20140112958 Pancreatic islets of transgenic LEA29Y animals for treating diabetes |
04/24/2014 | US20140112917 Diagnostic and therapeutic methods and compositions involving pten and breast cancer |
04/24/2014 | US20140112904 Method for enhancing the cleavage activity of i-crei derived meganucleases |
04/24/2014 | US20140112895 Glp-1 promoter mediated insulin expression for the treatment of diabetes |
04/24/2014 | US20140109472 Pathogen resistant citrus compositions, organisms, systems, and methods |
04/23/2014 | EP2722402A1 Method for separating, detecting or enriching different DNA species |
04/23/2014 | EP2722401A1 Addition of an adaptor by invasive cleavage |
04/23/2014 | EP2722395A1 Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection |
04/23/2014 | EP2722393A1 Method for producing useful chemical substance from terephthalic acid potassium salt |
04/23/2014 | EP2722392A2 Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis |
04/23/2014 | EP2722391A1 Method for plant improvement |
04/23/2014 | EP2722390A1 Regulation of inducible promoters |
04/23/2014 | EP2722389A2 Method for enhancing the production yield of human papillomavirus l1 protein |
04/23/2014 | EP2722388A1 Nucleic acid probe for assaying nucleic acids |
04/23/2014 | EP2722343A1 ANTI-erbB3 ANTIBODY |
04/23/2014 | EP2722337A1 Production of a HCMV based vaccine in human amniocyte cell lines |
04/23/2014 | EP2721182A1 Automated size selection of nucleic acids |
04/23/2014 | EP2721181A2 Methods and materials for assessing allelic imbalance |
04/23/2014 | EP2721168A1 Methods of producing carbamoyl phosphate and urea |
04/23/2014 | EP2721167A1 New means and methods for producing propanediol |
04/23/2014 | EP2721160A2 Compositions and methods for making and biocontaining auxotrophic transgenic plants |
04/23/2014 | EP2721159A1 Cassettes and methods for transforming and selecting yeast transformants by homologous recombination |
04/23/2014 | EP2721158A1 Computationally optimized broadly reactive antigens for h1n1 influenza |
04/23/2014 | EP2721157A1 New treatment for muscular dystrophies |
04/23/2014 | EP2721156A2 Antisense modulation of fibroblast growth factor receptor 4 expression |
04/23/2014 | EP2721155A2 Identifying markers of caloric restriction and caloric restriction mimetics |
04/23/2014 | EP2721154A1 Methods for preparative in vitro cloning |
04/23/2014 | EP2721153A2 Synthetic gene clusters |
04/23/2014 | EP2721152A1 Dimeric binding proteins based on modified ubiquitins |
04/23/2014 | EP2721063A1 Pcsk9-binding polypeptides and methods of use |
04/23/2014 | EP2721056A1 Human fusion proteins comprising interferons and targeted modified ubiquitin proteins |
04/23/2014 | CN103748236A Safe sequencing system |
04/23/2014 | CN103748235A Detection of saxitoxin-producing dinoflagellates |
04/23/2014 | CN103748230A Methods and compositions for introduction of exogenous dsrna into plant cells |
04/23/2014 | CN103748229A Improved baculovirus expression systems |
04/23/2014 | CN103748228A Mutant bacillus thuringiensis CRY genes and methods of use |
04/23/2014 | CN103748227A Brassica gat event dp-073496-4 and compositions and methods for the identification and/or detection thereof |